- Home
- TALO vs RCKT Comparison
TALO vs RCKT Comparison
Compare TALO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- RCKT
- Stock Information
- Founded
- TALO 2011
- RCKT 1999
- Country
- TALO United States
- RCKT United States
- Employees
- TALO N/A
- RCKT N/A
- Industry
- TALO Oil & Gas Production
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- RCKT Health Care
- Exchange
- TALO Nasdaq
- RCKT Nasdaq
- Market Cap
- TALO 1.5B
- RCKT 326.4M
- IPO Year
- TALO N/A
- RCKT N/A
- Fundamental
- Price
- TALO $8.67
- RCKT $2.90
- Analyst Decision
- TALO Buy
- RCKT Buy
- Analyst Count
- TALO 8
- RCKT 13
- Target Price
- TALO $14.25
- RCKT $18.50
- AVG Volume (30 Days)
- TALO 4.0M
- RCKT 4.3M
- Earning Date
- TALO 08-06-2025
- RCKT 08-04-2025
- Dividend Yield
- TALO N/A
- RCKT N/A
- EPS Growth
- TALO N/A
- RCKT N/A
- EPS
- TALO 0.14
- RCKT N/A
- Revenue
- TALO $2,055,748,000.00
- RCKT N/A
- Revenue This Year
- TALO N/A
- RCKT N/A
- Revenue Next Year
- TALO N/A
- RCKT N/A
- P/E Ratio
- TALO $59.96
- RCKT N/A
- Revenue Growth
- TALO 31.54
- RCKT N/A
- 52 Week Low
- TALO $6.23
- RCKT $2.19
- 52 Week High
- TALO $12.71
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- TALO 51.52
- RCKT 41.69
- Support Level
- TALO $8.19
- RCKT $2.40
- Resistance Level
- TALO $8.79
- RCKT $2.70
- Average True Range (ATR)
- TALO 0.36
- RCKT 0.21
- MACD
- TALO -0.07
- RCKT 0.15
- Stochastic Oscillator
- TALO 29.13
- RCKT 73.53
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.